Over the past year, we have witnessed rapid geopolitical shifts, stronger domestic priorities in the United States, and new questions about multilateral cooperation (UN/WHO). This provides a valuable backdrop for discussing how the Nordic countries and Europe can strengthen cooperation, preparedness, and competitiveness within the pharmaceutical and MedTech industries – while maintaining a constructive relationship with the United States.
Over the past year, we have witnessed rapid geopolitical shifts, stronger domestic priorities in the United States, and new questions about multilateral cooperation (UN/WHO). This provides a valuable backdrop for discussing how the Nordic countries and Europe can strengthen cooperation, preparedness, and competitiveness within the pharmaceutical and MedTech industries – while maintaining a constructive relationship with the United States.
Over the past year, we have witnessed rapid geopolitical shifts, stronger domestic priorities in the United States, and new questions about multilateral cooperation (UN/WHO). This provides a valuable backdrop for discussing how the Nordic countries and Europe can strengthen cooperation, preparedness, and competitiveness within the pharmaceutical and MedTech industries – while maintaining a constructive relationship with the United States.
